These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 569015)

  • 21. [A technique for determining the proportion of the clonogenic cells in S phase in ENT6 cell cultures and tumors].
    Rockwell S; Frindel E; Tubiana M
    Cell Tissue Kinet; 1976 Jul; 9(4):313-23. PubMed ID: 1277264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT; Dembs NL; Ublacker GA
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of three nitrosoureas on human lymphocytes. Hypothesis of a specific effect on lymphocyte subpopulations.
    Levallois C; Mani JC; Montero JL; Oiry J; Imbach JL
    Farmaco Sci; 1981 Nov; 36(11):947-56. PubMed ID: 7308461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD
    Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
    Joiner MC; Steel GG; Stephens TC
    Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
    Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma cells synchronized by centrifugal elutriation.
    Grdina DJ; Sigdestad CP; Peters LJ
    Br J Cancer; 1979 Feb; 39(2):152-8. PubMed ID: 435364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines.
    Tew KD; Dean SW; Gibson NW
    Cancer Chemother Pharmacol; 1987; 19(4):291-5. PubMed ID: 2954712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative dose-response relations for the cytotoxic activity of chloroethylnitrosoureas in cell culture.
    Weinkam RJ; Deen DF
    Cancer Res; 1982 Mar; 42(3):1008-14. PubMed ID: 7059967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1975 Apr; 31(4):417-23. PubMed ID: 1156523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CCNU on hematopoiesis in rats.
    Haas RJ; Rohruber W; Netzel B; Lau E
    Cancer Treat Rep; 1979 Mar; 63(3):377-83. PubMed ID: 427820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (I). Centrifugal elutriation.
    Siemann DW; Keng PC
    Br J Cancer; 1987 Jan; 55(1):33-6. PubMed ID: 3814473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Oguro M; Yanagawa T; Takenaga K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell proliferation in EMT6 tumors treated with single doses of x-rays or hydroxyurea. I. Experimental results.
    Rockwell S; Frindel E; Valleron AJ; Tubiana M
    Cell Tissue Kinet; 1978 May; 11(3):279-89. PubMed ID: 657234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proliferative status of microcolony-forming cells in mouse small intestine.
    Hendry JH; Moore JV; Potten CS
    Cell Tissue Kinet; 1984 Jan; 17(1):41-7. PubMed ID: 6362884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.